Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.47% is 30% above its 5-year average of 6.49%, near the high end of its 5-year range (3.47%–8.47%).
As of the fiscal period ended Tuesday, March 31, 2026. 8.31% above its 12-month average of 7.82%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
8.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
7.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
6.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
6.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
6.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
7.64%
CURRENT VS TTM AVG
+8.31%
CURRENT VS 3Y AVG
+18.88%
CURRENT VS 5Y AVG
+30.44%
CURRENT VS 10Y AVG
+37.42%
CURRENT VS 15Y AVG
+25.61%
CURRENT VS 20Y AVG
+10.86%
SECTOR MEDIAN · HEALTHCARE
8.81%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-3.86%
vs the sector median at left
STERIS plc
Market Cap
$23.06B
Return on Invested Capital (ROIC)
8.47%
TTM Avg
7.82%
3Y Avg
7.13%
5Y Avg
6.49%
Market Cap
$23.41B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
Market Cap
$23.66B
Return on Invested Capital (ROIC)
-29.70%
TTM Avg
-31.12%
3Y Avg
-12.69%
5Y Avg
0.19%
Market Cap
$22.26B
Return on Invested Capital (ROIC)
16.13%
TTM Avg
15.79%
3Y Avg
14.56%
5Y Avg
13.09%
Market Cap
$24.84B
Return on Invested Capital (ROIC)
20.58%
TTM Avg
10.42%
3Y Avg
9.36%
5Y Avg
7.13%
Market Cap
$25.06B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
14.65%
3Y Avg
16.90%
5Y Avg
17.70%
Market Cap
$26.25B
Return on Invested Capital (ROIC)
8.43%
TTM Avg
7.70%
3Y Avg
8.24%
5Y Avg
10.04%
Market Cap
$26.27B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$19.04B
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-3.96%
3Y Avg
-1.19%
5Y Avg
-0.87%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $23.06B | 8.47% | 7.82% | 7.13% | 6.49% |
| BioNTech SE (BNTX)vs › | $23.41B | -3.14% | -4.79% | 9.55% | 20.42% |
| Moderna, Inc. (MRNA)vs › | $23.66B | -29.70% | -31.12% | -12.69% | 0.19% |
| United Therapeutics Corporation (UTHR)vs › | $22.26B | 16.13% | 15.79% | 14.56% | 13.09% |
| Incyte Corporation (INCY)vs › | $24.84B | 20.58% | 10.42% | 9.36% | 7.13% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.06B | 13.62% | 14.65% | 16.90% | 17.70% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.25B | 8.43% | 7.70% | 8.24% | 10.04% |
| Labcorp Holdings Inc. (LH)vs › | $26.27B | 7.39% | 6.30% | 5.64% | 7.56% |
| Viatris Inc. (VTRS)vs › | $19.04B | -7.95% | -3.96% | -1.19% | -0.87% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.69B | 5.48% | 5.58% | 5.01% | 3.94% |
ROIC
8.5%
ROE
8.4%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | 8.47% |
| 2025-03-31 | 7.17% |
| 2024-03-31 | 6.42% |
| 2023-03-31 | 6.44% |
| 2022-03-31 | 3.47% |
| 2021-03-31 | 6.99% |
| 2020-03-31 | 8.86% |
| 2019-03-31 | 7.37% |
| 2018-03-31 | 6.84% |
| 2017-03-31 | 2.98% |
| 2016-03-31 | 2.79% |
| 2015-03-31 | 8.09% |
| 2014-03-31 | 8.70% |
| 2013-03-31 | 11.09% |
| 2012-03-31 | 12.72% |
| 2011-03-31 | 5.47% |
| 2010-03-31 | 13.10% |
| 2009-03-31 | 11.49% |
| 2008-03-31 | 7.88% |
| 2007-03-31 | 8.46% |
| 2006-03-31 | 6.68% |
| 2005-03-31 | 8.83% |
| 2004-03-31 | 9.94% |
| 2003-03-31 | 11.40% |
| 2002-03-31 | 7.54% |
| 2001-03-31 | 0.80% |
| 2000-03-31 | 2.46% |
| 1999-03-31 | 12.80% |
| 1998-03-31 | 12.17% |
| 1997-03-31 | 22.16% |
